Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
Melina Verso(University of Perugia), Sergio Bertoglio(University of Genoa), Antonio Lazzaro(Guglielmo da Saliceto Hospital), Pieter W. Kamphuisen(University Medical Center Groningen), Walter Ageno(University of Padua), Giancarlo Agnelli(University of Perugia), Stefano Mosca(University of Perugia), Francesco Paoletti(University of Florence), Mario Bazzan(Ospedale San Giovanni Bosco), Maurizio Paciaroni(Misericordia University)
Cited by 126
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Oral Anticoagulant Therapy
|CHEST Journal|2012|1.5k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery
|Annals of Surgery|2005|688